Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > Nanopoint's Far Eastern Clients to be Well-Served by a Network of Experienced, Regional Distributors Throughout Asia

Abstract:
Nanopoint, Inc. has announced its strong network of Asian distributors who include DayMoon Industries of Korea;, DI Biotech LTD of Korea; JC Biotech of Korea; JK Bio of Delhi, India; Joagene BioScience of Korea, Quantum Design China of China; Quantum Design Japan of Japan; and Trade 21 Pte., LTD of Singapore and SinWan Biotech LTD of Taiwan.

Nanopoint's Far Eastern Clients to be Well-Served by a Network of Experienced, Regional Distributors Throughout Asia

Honolulu, HI | Posted on April 23rd, 2008

Nanopoint Inc., an award-winning developer of cellTRAY® Fluidics and Imaging System products, is announcing the strong network of Asian distributorships the Company is building in order to provide the best-of-the-best customer sales and service in the expanding life science markets throughout the Far East. Nanopoint's carefully selected distributors in Korea, India, China, Japan, Singapore and Taiwan will bring their valuable understanding of Asia's diverse commercial cultures and help to expand the end-user base of the Company's total range of cellTRAY products. Nanopoint's level of precision for studying live cells is not available in any other commercially available live cell imaging system. The Asian distributors announced to-date include DayMoon Industries of Korea;, DI Biotech LTD of Korea; JC Biotech of Korea; JK Bio of Delhi, India; Joagene BioScience of Korea, Quantum Design China of China; Quantum Design Japan of Japan; and Trade 21 Pte., LTD of Singapore and SinWan Biotech LTD of Taiwan.

"We are honored that Nanopoint has contracted with such an outstanding group of distributors to represent us in Asia. In today's global marketplace, it's vitally important for us to have representatives on-the-ground who understand and respect the business culture of our clients and who deeply understand the technical specifications and benefits of our cellTRAY family of products," said Cathy Owen, Nanopoint's CEO. "Nanopoint is building a global brand; our headquarters in Hawaii provides a strong geographic base for building strategic market share in Asia as well as in the West--including the Americas and Europe."

Nanopoint is building a global brand; our headquarters in Hawaii provides a strong geographic base for building strategic market share in Asia as well as in the West--including the Americas and Europe.

In June 2008, Nanopoint will formally launch its cellTRAY® Imaging System Model CT-2000 and make its cellTRAY Fluidics System Model CT-2000F commercially available for purchase. Nanopoint's cellTRAY® Imaging System Model CT-2000 adds in all the precision navigation and image acquisition capabilities for drug screening and targeted nanoparticle delivery applications. The Model CT-2000 offers the most advanced, on-microscope, environmental control system available. The system allows experiments to run on an inverted microscope for extended periods of time, enabling time-lapse imaging of live cells over the course of several days.

Nanopoint's cellTRAYs have been carefully designed to enable scientists to easily move from a Petri dish or microtiter plate style of research to a more precise live cell imaging system. Each of the products has been designed to allow a methodical migration to a miniaturized research platform starting with the cellTRAY, a microscope slide-sized high precision etched well device that can be used with any laboratory equipment supporting slides, to the cellTRAY Imaging System Model CT-1000 which is an add-on to an upright or inverted microscope, to the cellTRAY Fluidics System Model CT-2000F and the cellTRAY Imaging System Model CT-2000 which can be easily added to an inverted microscope. Nanopoint's proprietary software provides the navigation, camera, shutter and filter controls, auto-focus, and microfluidics control necessary for today's demanding live cell imaging applications.

####

About Nanopoint, Inc.
Nanopoint, Inc. is a privately-held nano-biotechnology company that is revolutionizing the study and treatment of diseases with its live cell imaging solutions. Nanopoint's cellTRAY Fluidics and Imaging System products have broad applications to life science research, drug discovery, and biopharmaceutical production as well as other areas where live cell analysis is important.

For more information, please click here

Contacts:
Corporate Contact:
Ken Perel
Nanopoint, Inc.
kperel(at)nanopointimaging.com
808-457-1145 Phone
808-537-4245 Fax

Media Contact:
Sandra Kay Helsel, Ph.D.
SK Helsel & Associates
www.skhelsel.com
skhelsel(at)skhelsel.com
520-325-4636 Office
520-390-8184 Cell

Copyright © PRWeb™

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

UTSA study describes new minimally invasive device to treat cancer and other illnesses: Medicine diffusion capsule could locally treat multiple ailments and diseases over several weeks December 3rd, 2016

Novel Electrode Structure Provides New Promise for Lithium-Sulfur Batteries December 3rd, 2016

Research Study: MetaSOLTM Shatters Solar Panel Efficiency Forecasts with Innovative New Coating: Coating Provides 1.2 Percent Absolute Enhancement to Triple Junction Solar Cells December 2nd, 2016

Deep insights from surface reactions: Researchers use Stampede supercomputer to study new chemical sensing methods, desalination and bacterial energy production December 2nd, 2016

Throwing new light on printed organic solar cells December 1st, 2016

Imaging

Deep insights from surface reactions: Researchers use Stampede supercomputer to study new chemical sensing methods, desalination and bacterial energy production December 2nd, 2016

Controlled electron pulses November 30th, 2016

Nanomedicine

UTSA study describes new minimally invasive device to treat cancer and other illnesses: Medicine diffusion capsule could locally treat multiple ailments and diseases over several weeks December 3rd, 2016

Nanobiotix Provides Update on Global Development of Lead Product NBTXR3: Seven clinical trials across the world: More than 2/3 of STS patients recruited in the “act.in.sarc” Phase II/III trial: Phase I/II prostate cancer trial now recruiting in the U.S. November 28th, 2016

From champagne bubbles, dance parties and disease to new nanomaterials: Understanding nucleation of protein filaments might help with Alzheimer's Disease and type 2 Diabetes November 24th, 2016

Nanopolymer-modified protein array can pinpoint hard-to-find cancer biomarker November 17th, 2016

Announcements

UTSA study describes new minimally invasive device to treat cancer and other illnesses: Medicine diffusion capsule could locally treat multiple ailments and diseases over several weeks December 3rd, 2016

Novel Electrode Structure Provides New Promise for Lithium-Sulfur Batteries December 3rd, 2016

Research Study: MetaSOLTM Shatters Solar Panel Efficiency Forecasts with Innovative New Coating: Coating Provides 1.2 Percent Absolute Enhancement to Triple Junction Solar Cells December 2nd, 2016

Deep insights from surface reactions: Researchers use Stampede supercomputer to study new chemical sensing methods, desalination and bacterial energy production December 2nd, 2016

Alliances/Trade associations/Partnerships/Distributorships

Leti and Grenoble Partners Demonstrate World’s 1st Qubit Device Fabricated in CMOS Process: Paper by Leti, Inac and University of Grenoble Alpes Published in Nature Communications November 28th, 2016

Mechanism for sodium storage in 2-D material: Tin selenide is an effective host for storing sodium ions, making it a promising material for sodium ion batteries October 27th, 2016

Enterprise In Space Partners with Sketchfab and 3D Hubs for NewSpace Education October 13th, 2016

Arrowhead and Spring Bank Announce Clinical Collaboration for ARC-520 and SB 9200 in Chronic Hepatitis B October 6th, 2016

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project